Repevax vaccine suspension for injection 0.5ml pre-filled syringes
Pajjiż: Ingilterra
Lingwa: Ingliż
Sors: MHRA (Medicines & Healthcare Products Regulatory Agency)
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
Diphtheria toxoid; Tetanus toxoid; Pertussis antigens; Human poliovirus type 1 inactivated; Human poliovirus type 2 inactivated; Human poliovirus type 3 inactivated
Disponibbli minn:
sanofi pasteur MSD Ltd
Kodiċi ATC:
J07CA02
INN (Isem Internazzjonali):
Diphtheria toxoid; Tetanus toxoid; Pertussis antigens; Human poliovirus type 1 inactivated; Human poliovirus type 2 inactivated; Human poliovirus type 3 inactivated
Għamla farmaċewtika:
Suspension for injection
Rotta amministrattiva:
Subcutaneous; Intramuscular
Klassi:
No Controlled Drug Status
Tip ta 'preskrizzjoni:
Valid as a prescribable product
Sommarju tal-prodott:
BNF: 14040000
